VeriMomhexapeptide-12은 임신 중 안전한가요?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
Pregnancy-safe products containing hexapeptide-12
Related ingredients
Frequently asked questions
- hexapeptide-12은 임신 중 안전한가요?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
- hexapeptide-12은 모유 수유 중 안전한가요?
- No data indicating reproductive or lactation toxicity, no mechanistic evidence for transfer into breastmilk, and no harmonised classifications. With no demonstrated systemic bioavailability from topical use, breastfeeding exposure is considered negligible. Sources: SCCS/CIR (no opinion), PubMed (no lactation studies), PubChem/CosIng (no hazard data).
- hexapeptide-12은 아기 피부에 안전한가요?
- No infant-specific toxicity or developmental data identified. Hazard and mechanism remain 0 due to lack of evidence or harmonised classification. Dermal exposure score increased by +1 for baby skin (to 1) because peptides are not completely non‑absorbable and infant skin has a higher surface-area-to-weight ratio and immature barrier, so a low but measurable exposure is plausible even if adult absorption is negligible. Sources: general dermal absorption principles (peptide physicochemistry), CosIng/PubChem (ingredient listings), PubMed (no infant studies).
- VeriMom은 hexapeptide-12을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 hexapeptide-12을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 hexapeptide-12 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.